82 related articles for article (PubMed ID: 3548958)
1. Clinical trial of plasma perfusion over immobilized staphylococcal protein A in metastatic breast cancer.
Ventura GJ; Buzdar AU; Kau S; Lichtiger B; Hortobagyi GN
Cancer Treat Rep; 1987 Apr; 71(4):411-3. PubMed ID: 3548958
[TBL] [Abstract][Full Text] [Related]
2. Staphylococcal protein A immunoadsorptive column induces mitogenicity in perfused plasma.
Bertram JH; Hengst JC; Mitchell MS
J Biol Response Mod; 1984; 3(3):235-40. PubMed ID: 6379107
[TBL] [Abstract][Full Text] [Related]
3. A trial of autologous plasma perfusion over protein A in patients with breast cancer.
Fer MF; Beman J; Stevenson HC; Maluish A; Moratz C; Delawter T; Foon K; Herberman RB; Oldham RK; Terman DS
J Biol Response Mod; 1984; 3(3):352-8. PubMed ID: 6235326
[No Abstract] [Full Text] [Related]
4. Clinical trials with Staphylococcus aureus and protein A in the treatment of malignant disease.
Messerschmidt GL; Bowles CA; Henry DH; Deisseroth AB
J Biol Response Mod; 1984; 3(3):325-9. PubMed ID: 6379115
[TBL] [Abstract][Full Text] [Related]
5. Staphylococcal Protein A column: correlation of mitogenicity of perfused plasma with clinical response.
Bertram JH; Grunberg SM; Shulman I; Apuzzo ML; Boquiren D; Kunkel L; Hengst JC; Nelson J; Waugh WJ; Plotkin D
Cancer Res; 1985 Sep; 45(9):4486-94. PubMed ID: 4028030
[TBL] [Abstract][Full Text] [Related]
6. Cyclophosphamide/mitoxantrone/melphalan (CMA) regimen prior to autologous bone marrow transplantation (ABMT) in metastatic breast cancer.
Gisselbrecht C; Extra JM; Lotz JP; Devaux Y; Janvier M; Peny AM; Guillevin L; Bremond D; Delain M; Herbrecht R; Lepage E; Maraninchi D
Bone Marrow Transplant; 1996 Nov; 18(5):857-63. PubMed ID: 8932837
[TBL] [Abstract][Full Text] [Related]
7. Histological and ultrastructural changes in breast adenocarcinoma after treatment with plasma perfused over immobilized protein A.
Daskal Y; Mattioli CA; Kao-Jen J; Terman DS
Cancer Res; 1984 May; 44(5):2225-35. PubMed ID: 6713411
[TBL] [Abstract][Full Text] [Related]
8. Clinical experiences with extracorporeal immunoperfusion of plasma from cancer patients.
Korec S; Smith FP; Schein PS; Phillips TM
J Biol Response Mod; 1984; 3(3):330-5. PubMed ID: 6379116
[TBL] [Abstract][Full Text] [Related]
9. Phase I trial of TALL-104 cells in patients with refractory metastatic breast cancer.
Visonneau S; Cesano A; Porter DL; Luger SL; Schuchter L; Kamoun M; Torosian MH; Duffy K; Sickles C; Stadtmauer EA; Santoli D
Clin Cancer Res; 2000 May; 6(5):1744-54. PubMed ID: 10815893
[TBL] [Abstract][Full Text] [Related]
10. [Antitumor responses after reinfusion of autologous plasma perfused over immobilized protein A: a study in patients at advanced stages of cancer].
Yamamoto T; Okada T; Seshimo T; Abe M; Yano S; Tarumi T; Naitoh A; Tamura K; Nakase A
Nihon Gan Chiryo Gakkai Shi; 1990 Jan; 25(1):13-24. PubMed ID: 2324585
[TBL] [Abstract][Full Text] [Related]
11. Ultrastructural changes in breast tumors of patients following treatment with plasma perfused over immobilized protein A.
Daskal Y; Mattioli CA; Terman DS
J Biol Response Mod; 1984; 3(3):247-54. PubMed ID: 6379108
[No Abstract] [Full Text] [Related]
12. Treatment of advanced malignancy with plasma perfused over staphylococcal protein A.
MacKintosh FR; Bennett K; Schiff S; Shields J; Hall SW
West J Med; 1983 Jul; 139(1):36-40. PubMed ID: 6624080
[TBL] [Abstract][Full Text] [Related]
13. Phase II study of paclitaxel and epirubicin as first-line therapy in patients with metastatic breast cancer.
Lück HJ; Thomssen C; du Bois A; Untch M; Lisboa B; Köhler G; Diergarten K
Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-35-S17-39. PubMed ID: 9374090
[TBL] [Abstract][Full Text] [Related]
14. Initially metastatic breast carcinoma has a distinct disease pattern but an equivalent outcome compared with recurrent metastatic breast carcinoma.
Jimeno A; Amador ML; González-Cortijo L; Tornamira MV; Ropero S; Valentín V; Hornedo J; Cortés-Funes H; Colomer R
Cancer; 2004 May; 100(9):1833-42. PubMed ID: 15112263
[TBL] [Abstract][Full Text] [Related]
15. Clinical trials with staphylococcal protein A.
Bensinger WI; Buckner CD; Clift RA; Thomas ED
J Biol Response Mod; 1984; 3(3):347-51. PubMed ID: 6379119
[TBL] [Abstract][Full Text] [Related]
16. Clinical trials in metastatic breast cancer to bone: past--present--future.
Body JJ
Can J Oncol; 1995 Dec; 5 Suppl 1():16-27. PubMed ID: 8853520
[TBL] [Abstract][Full Text] [Related]
17. Bisphosphonates for cancer patients: why, how, and when?
Body JJ; Mancini I
Support Care Cancer; 2002 Jul; 10(5):399-407. PubMed ID: 12136223
[TBL] [Abstract][Full Text] [Related]
18. Beta-interferon and interleukin-2 prolong more than three times the survival of 26 consecutive endocrine dependent breast cancer patients with distant metastases: an exploratory trial.
Nicolini A; Carpi A
Biomed Pharmacother; 2005 Jun; 59(5):253-63. PubMed ID: 15913946
[TBL] [Abstract][Full Text] [Related]
19. Phase I trial of Staphylococcus aureus Cowan I immunoperfusion.
Messerschmidt G; Bowles C; Dean D; Parker M; Lester R; Dowling R; Holohan T; Osborne L; Schaff BF; McCormack K; Corbitt R; Phillips T; Glatstein E; Deisseroth A
Cancer Treat Rep; 1982 Dec; 66(12):2027-31. PubMed ID: 7139644
[TBL] [Abstract][Full Text] [Related]
20. Vinorelbine and 5-fluorouracil bolus and/or continuous venous infusion plus levofolinic acid as second-line chemotherapy for metastatic breast cancer: an analysis of results in clinical practice of the Gruppo Oncologico Italia Meridionale (GOIM).
Gebbia V; Caruso M; Borsellino N; Ajello R; Tirrito ML; Chiarenza M; Valenza R; Verderame F; Varvara F; Marrazzo A; Bajardi E; Ferrao F; Bordonaro R; Tralongo P
Anticancer Res; 2006; 26(4B):3143-50. PubMed ID: 16886648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
